GLP and GMP are the two regulatory frameworks that govern laboratory weighing in pharmaceutical, food, chemical, and research environments. Both require calibrated, documented, traceable weighing equipment. Both treat a balance as a critical instrument whose performance must be verified, recorded, and audit-ready. The difference between them — what each framework actually requires from a laboratory balance, who it applies to, and what documentation it demands — is where most laboratory professionals have gaps in their understanding.
This article explains what GLP and GMP each require from a laboratory balance, where the frameworks overlap, where they diverge, and what a compliant balance program looks like under each one.
Table of Contents
What GLP and GMP Are — and Why the Distinction Matters
GLP and GMP are not interchangeable. They govern different stages of product development and manufacturing, apply to different laboratory activities, and impose different requirements on the people, equipment, and documentation involved.
Good Laboratory Practice (GLP) is a quality system that governs non-clinical laboratory studies — the safety and efficacy testing performed before a product enters human clinical trials. As defined under FDA 21 CFR Part 58 and the OECD Principles of GLP, GLP covers the organizational processes and conditions under which non-clinical studies are planned, performed, monitored, recorded, reported, and archived. GLP applies to pharmaceutical and biotechnology companies, contract research organizations, and testing laboratories conducting safety studies for regulatory submissions.
Good Manufacturing Practice (GMP) governs the manufacturing, processing, and quality control of pharmaceutical products intended for sale. As confirmed by Dot Compliance, GMP is production and process-focused — it ensures each product batch is manufactured according to pre-defined quality criteria. In the United States, GMP for pharmaceutical manufacturing is defined under FDA 21 CFR Part 211. A laboratory balance operating in a GMP quality control environment is subject to Part 211’s requirements for equipment calibration, maintenance, and documentation.
The practical consequence of this distinction: a balance used to weigh test articles in a non-clinical safety study operates under GLP. A balance used to weigh active pharmaceutical ingredients during batch manufacturing or QC testing operates under GMP. Some laboratories operate under both simultaneously — a pharmaceutical QC laboratory may conduct both release testing (GMP) and method validation studies (GLP) using the same balance, requiring both frameworks’ requirements to be satisfied.
What GLP Requires From a Laboratory Balance
Under FDA 21 CFR Part 58 and the OECD GLP Principles, laboratory equipment used in a GLP study must satisfy four core requirements.
Fitness for purpose: The balance must be appropriate for the measurements it is used to perform. A balance used to weigh milligram quantities of a test article in a toxicology study must have readability fine enough to detect the mass differences that matter in that study. Using a balance with insufficient readability for the application is a GLP violation regardless of how well the balance is otherwise maintained.
Calibration and maintenance: As confirmed by Pharma Tips, GLP requires that all equipment directly impacting test results be calibrated at defined intervals using appropriate methods. Calibration must be traceable to national or international standards — in the United States, traceability to NIST is the standard. Calibration intervals must be documented in a calibration schedule and adhered to as part of the laboratory’s Standard Operating Procedures.
Documentation: GLP documentation requirements are governed by the ALCOA+ principle — data must be Attributable, Legible, Contemporaneous, Original, and Accurate, plus Complete, Consistent, Enduring, and Available. As LCGC International confirms, this means recording the balance used, its calibration status, the weight recorded, the operator ID, and the date and time for every weighing event that is part of a GLP study record. A weighing recorded after the fact, from memory, or without the balance’s identification is not GLP-compliant, regardless of whether the number is accurate.
Standard Operating Procedures: Every balance-related activity — preparation, calibration, verification, use, maintenance, and out-of-tolerance response — must be governed by written, approved SOPs. The SOPs must be accessible at the balance location, version-controlled, and followed without deviation. Deviations must be documented and assessed for impact on study data.
What GMP Requires From a Laboratory Balance
GMP requirements for laboratory balances in pharmaceutical quality control environments are defined primarily under FDA 21 CFR Part 211 and, internationally, under EMA EudraLex Volume 4. The requirements are more prescriptive than GLP in several areas.
Equipment qualification: A balance entering GMP service must be qualified through a formal process. As confirmed by the European Pharmaceutical Review, this involves three stages: Installation Qualification (IQ) — confirming the balance was installed correctly per manufacturer specifications; Operational Qualification (OQ) — confirming the balance performs within specification under its intended use conditions; and Performance Qualification (PQ) — confirming consistent performance over time under actual operating conditions. IQ/OQ documentation packages are available from major balance manufacturers, including Mettler Toledo, Sartorius, and Rice Lake Weighing Systems.
Calibration with defined intervals: As confirmed by GMP Compliance, FDA 21 CFR Part 211 requires measuring and weighing equipment to be calibrated at defined intervals by appropriate methods, with adequate records maintained. The calibration interval must be defined in a written procedure, justified based on usage and risk, and strictly adhered to. A balance whose calibration interval has lapsed — even by one day — is not in compliance for GMP use.
Calibration with representative weights: A GMP inspection finding cited by GMP Compliance specifically criticizes laboratories that calibrate a balance with a weight that is not representative of the quantities being weighed on it. Calibration must cover the weighing range actually used — not just a convenient mid-range point. For a balance used to weigh 10–100 mg quantities of an active pharmaceutical ingredient, calibration must verify performance in that range.
USP Chapter 41 minimum weight requirement: Under USP Chapter 41, a balance used in pharmaceutical weighing must demonstrate that its minimum weight — the smallest quantity it can weigh with acceptable relative standard deviation — is below the smallest quantity required by the method. USP 41 specifies that repeatability, expressed as twice the standard deviation of ten replicate weighings, must not exceed 0.10% of the test quantity. This is not simply a readability specification — it is a demonstrated performance requirement that must be verified at commissioning and reconfirmed periodically.
Electronic records and audit trail — FDA 21 CFR Part 11: Where electronic balance records replace paper records in a GMP environment, the electronic system must comply with FDA 21 CFR Part 11. This requires a secure, time-stamped audit trail for every weighing event, calibration event, and parameter change — with individual operator identification and the ability to reconstruct the complete history of every record. Balances without Part 11-compliant audit trail capability cannot be used in a fully electronic GMP record environment without supplementary paper records.
Where GLP and GMP Overlap for Laboratory Balances
Despite their differences, GLP and GMP share four requirements that apply to laboratory balances in both frameworks.
Calibration traceability: Both GLP and GMP require that balance calibration be traceable to NIST or an equivalent national metrology institute. An in-house calibration using uncertified test weights satisfies neither framework as a formal calibration event.
Documented SOPs: Both frameworks require written, approved, version-controlled SOPs covering all balance operations. The SOPs must be accessible at the point of use and followed without undocumented deviation.
Out-of-tolerance response: Both frameworks require a documented investigation when a balance is found out of tolerance. The investigation must assess the impact on all data generated since the last successful calibration event — a potentially significant exercise depending on the interval involved and the volume of work performed.
Data integrity: Both frameworks require that weighing records be attributable, contemporaneous, and protected from alteration. Electronic records must carry an audit trail. Paper records must be completed in ink at the time of the weighing event — not reconstructed afterward.
The GLP vs GMP Balance Requirements at a Glance
| Requirement | GLP | GMP |
|---|---|---|
| Primary regulation | FDA 21 CFR Part 58; OECD GLP | FDA 21 CFR Part 211; EMA EudraLex Vol 4 |
| Equipment qualification (IQ/OQ/PQ) | Not formally required | Required |
| Calibration traceability | NIST-traceable | NIST-traceable |
| Calibration interval | Defined in SOP | Defined in SOP — lapse is a compliance failure |
| Minimum weight (USP 41) | Not directly applicable | Required for pharmaceutical weighing |
| Audit trail (21 CFR Part 11) | Required for electronic records | Required for electronic records |
| ALCOA+ documentation | Required | Required |
| Out-of-tolerance impact assessment | Required | Required |
| Study Director responsibility | Yes — GLP-specific role | Not applicable |
Building a Compliant Balance Program Under GLP or GMP
A compliant laboratory balance program under either framework requires the same foundational elements, with GMP adding the formal equipment qualification layer.
Specification and selection: Document the balance’s required readability, capacity, and minimum weight before purchase. For GMP, write a User Requirements Specification (URS) and perform Design Qualification (DQ) — confirming the selected model meets the URS before purchase.
Installation and qualification: For GMP, perform IQ and OQ at installation and PQ after a defined period of use. For GLP, confirm the installation location meets the environmental requirements described in our article on what affects lab balance accuracy and document the confirmation.
Calibration program: Establish a written calibration schedule — daily verification, periodic formal external calibration with NIST-traceable reference weights, and a defined response procedure for out-of-tolerance findings. The calibration requirements are covered in full in our article on how to calibrate a lab balance.
SOPs: Write and approve SOPs covering balance preparation, calibration, routine use, maintenance, and out-of-tolerance response. Ensure SOPs are accessible at the balance location and that all users are trained and documented as competent.
Records: Maintain calibration certificates, verification logs, maintenance records, and all weighing records that form part of a GLP study or GMP batch record. Retention periods are defined by regulation — typically 5–7 years minimum under GLP for non-clinical studies, and for the life of the product plus additional years under GMP.
FAQs
What is the difference between GLP and GMP for laboratory balances?
GLP governs non-clinical research studies — the safety and efficacy testing performed before clinical trials — under FDA 21 CFR Part 58 and OECD GLP Principles. GMP governs pharmaceutical manufacturing and QC testing under FDA 21 CFR Part 211. Both require calibrated, documented, NIST-traceable balance calibration and written SOPs. GMP additionally requires formal equipment qualification (IQ/OQ/PQ), USP Chapter 41 minimum weight verification, and FDA 21 CFR Part 11 audit trail compliance for electronic records.
Does a laboratory balance need to be qualified for GMP use?
Yes. A balance entering GMP pharmaceutical service must complete Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) before it is placed into routine use. IQ/OQ documentation packages are available from major balance manufacturers and must be reviewed, approved, and retained as part of the balance’s qualification record.
What is USP Chapter 41, and how does it apply to lab balance compliance?
USP Chapter 41 defines the accuracy and minimum weight requirements for balances used in pharmaceutical weighing. It requires that the repeatability of the balance — expressed as twice the standard deviation of ten replicate weighings — must not exceed 0.10% of the test quantity. This means a balance must demonstrate that its minimum weighable quantity is below the smallest amount required by the method it is used for. It is a performance requirement, not just a readability specification.
What does ALCOA+ mean for laboratory balance records?
ALCOA+ is the data integrity standard required under both GLP and GMP. It requires that every weighing record be Attributable (linked to the operator), Legible, Contemporaneous (recorded at the time of weighing), Original, and Accurate — plus Complete, Consistent, Enduring, and Available. A weight recorded after the fact, from memory, or without balance identification does not satisfy ALCOA+ regardless of whether the number itself is correct.
What happens if a GMP balance is found out of calibration?
The balance must be taken out of service immediately. An impact assessment must be performed for all analyses conducted since the last successful calibration to determine whether any batch release decisions or QC results were affected. The balance is recalibrated and requalified before service return. The out-of-tolerance event, the impact assessment findings, and the corrective actions taken must all be documented in the laboratory’s quality system.
Conclusion
GLP and GMP impose different but overlapping requirements on laboratory balances. GLP focuses on data integrity, traceability, and documented SOPs for non-clinical research studies. GMP adds formal equipment qualification, USP Chapter 41 minimum weight verification, and 21 CFR Part 11 audit trail requirements for pharmaceutical manufacturing QC.
The common thread is calibration traceability, ALCOA+ documentation, and a defined response to out-of-tolerance findings. Laboratories that build their balance program around these shared requirements — and then layer the framework-specific additions appropriate to their regulatory context — produce the audit-ready evidence trail that both GLP and GMP inspectors look for.
For the pharmaceutical-specific requirements that extend these frameworks into the weighing of active pharmaceutical ingredients and dosage forms, see our article on pharmaceutical lab weighing and USP standards.
